We are live on ! Find out more
GC

Gratus Capital Portfolio holdings

AUM $2.5B
1-Year Est. Return 32.89%
This Fund
S&P 500
This Quarter Est. Return
+5.06%
1 Year Est. Return
+32.89%
3 Year Est. Return
+51.43%
5 Year Est. Return
+136.95%
10 Year Est. Return
AUM
$769M
AUM Growth
+$49.3M
Cap. Flow
+$15.9M
Cap. Flow %
2.07%
Top 10 Hldgs %
41.97%
Holding
187
New
3
Increased
43
Reduced
77
Closed
5

Top Buys

Rank Stock Value
1
ENB icon
Enbridge
ENB
+$6.26M
2
PFE icon
Pfizer
PFE
+$6.22M
3
DIS icon
Walt Disney
DIS
+$5.75M
4
SLB icon
SLB Ltd
SLB
+$1.24M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.21M

Sector Composition

Rank Sector Weight
1 Consumer Staples 30.89%
2 Healthcare 10.99%
3 Industrials 10.47%
4 Financials 9.58%
5 Technology 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STRM
176
DELISTED
Streamline Health Solutions
STRM
$145K 0.02%
5,721
FLG
177
Flagstar Bank National Association
FLG
$5.77B
$143K 0.02%
3,667
DNP icon
178
DNP Select Income Fund
DNP
$4.18B
$131K 0.02%
12,147
OPK icon
179
Opko Health
OPK
$921M
$89K 0.01%
18,225
+1,450
+9% +$8.41K
ABEV icon
180
Ambev
ABEV
$47.3B
$81K 0.01%
12,500
PDLI
181
DELISTED
PDL BioPharma, Inc.
PDLI
$36K ﹤0.01%
13,000
ATHX
182
DELISTED
Athersys, Inc. Common Stock
ATHX
$18K ﹤0.01%
400
GILD icon
183
Gilead Sciences
GILD
$161B
-2,683
Closed -$217K
T icon
184
AT&T
T
$165B
-7,866
Closed -$233K
V icon
185
Visa
V
$677B
-2,462
Closed -$259K
BBBY
186
DELISTED
Bed Bath & Beyond Inc
BBBY
-55,578
Closed -$1.3M
FDC
187
DELISTED
First Data Corporation
FDC
-27,700
Closed -$500K

Similar funds

Gratus Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Gratus Capital held 187 positions worth $769M, up 6.8% from $720M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Trading was light in Q4 2017: portfolio turnover was 4.3%. Gratus Capital opened 3 new positions and exited 5, leaving the 187-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Staples at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Industrials.

  • Gratus Capital's largest Q4 2017 buy was Enbridge: 162,652 shares worth $6.36M.
  • Gratus Capital added most to Pfizer in Q4 2017, an estimated $6.22M increase.
  • Gratus Capital's biggest Q4 2017 reduction was GE Aerospace, cutting an estimated $4.97M.
  • Gratus Capital fully exited Bed Bath & Beyond Inc in Q4 2017, selling an estimated $1.3M.
  • Gratus Capital's ten largest holdings make up 42% of its $769M portfolio in Q4 2017.
  • Gratus Capital opened 3 new positions and closed 5 in Q4 2017.
  • Gratus Capital's portfolio value rose 6.8% quarter-over-quarter to $769M.

Based on Gratus Capital's 13F filing for Q4 2017, filed 7 Feb 2018.